Modulation of gyrase-mediated DNA cleavage and cell killing by ATP

被引:19
作者
Li, TK [1 ]
Liu, LF [1 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA
关键词
D O I
10.1128/AAC.42.5.1022
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
uncoupler of oxidative phosphorylation, 2,4-dinitrophenol, and an aconitase inhibitor, fluoroacetic acid, both of which are known to lower the cellular ATP pool, protected Escherichia call cells from the bactericidal actions of gyrase poisons including quinolone antibiotics, nalidixic acid and ciprofloxacin, and the epipodophyllotoxins VP-16 and VM-26. Using purified E. coli DNA gyrase, we examined the effect of ATP on gyrase-mediated DNA cleavage in the presence of these gyrase poisons. ATP was shown to stimulate gyrase-mediated DNA cleavage from HO-to more than 100-fold in the presence of these gyrase poisons, ADP antagonized the stimulatory effect of ATP, consequently, gyrase-mediated DNA cleavage induced by gyrase poisons is modulated by the ATP concentration/ADP concentration ([ATP]/[ADP]) ratio. Coumermycin Al, an inhibitor of the ATPase subunit of DNA gyrase, like ADP, also effectively antagonized the stimulatory effect of ATP on gyrase-mediated DNA cleavage induced by gyrase poisons. Furthermore, coumermycin Al, like DNP and fluoroacetic acid, also protected cells from the bactericidal action of gyrase poisons, In the aggregate, our results are consistent with the notion that the [ATP]/[ADP] ratio, through its modulatory effect on the gyrase-mediated DNA cleavage, is an important determinant of cellular susceptibility to gyrase poisons.
引用
收藏
页码:1022 / 1027
页数:6
相关论文
共 41 条
[1]   THE 43-KILODALTON N-TERMINAL FRAGMENT OF THE DNA GYRASE-B PROTEIN HYDROLYZES ATP AND BINDS COUMARIN DRUGS [J].
ALI, JA ;
JACKSON, AP ;
HOWELLS, AJ ;
MAXWELL, A .
BIOCHEMISTRY, 1993, 32 (10) :2717-2724
[2]   NUCLEOTIDE-BINDING TO THE 43-KILODALTON N-TERMINAL FRAGMENT OF THE DNA GYRASE-B PROTEIN [J].
ALI, JA ;
ORPHANIDES, G ;
MAXWELL, A .
BIOCHEMISTRY, 1995, 34 (30) :9801-9808
[3]   EXPRESSION, DOMAIN-STRUCTURE, AND ENZYMATIC-PROPERTIES OF AN ACTIVE RECOMBINANT HUMAN DNA TOPOISOMERASE II-BETA [J].
AUSTIN, CA ;
MARSH, KL ;
WASSERMAN, RA ;
WILLMORE, E ;
SAYER, PJ ;
WANG, JC ;
FISHER, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (26) :15739-15746
[4]  
Beck W T, 1991, Semin Cancer Biol, V2, P235
[5]   Structure and mechanism of DNA topoisomerase II [J].
Berger, JM ;
Gamblin, SJ ;
Harrison, SC ;
Wang, JC .
NATURE, 1996, 379 (6562) :225-232
[6]  
DARPA P, 1990, CANCER RES, V50, P6919
[7]   MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI .3. CONDITIONS REQUIRED FOR LETHALITY [J].
DEITZ, WH ;
COOK, TM ;
GOSS, WA .
JOURNAL OF BACTERIOLOGY, 1966, 91 (02) :768-&
[8]   BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF P170 AND P180 FORMS OF TOPOISOMERASE-II [J].
DRAKE, FH ;
HOFMANN, GA ;
BARTUS, HF ;
MATTERN, MR ;
CROOKE, ST ;
MIRABELLI, CK .
BIOCHEMISTRY, 1989, 28 (20) :8154-8160
[9]   INHIBITORS OF DNA TOPOISOMERASES [J].
DRLICA, K ;
FRANCO, RJ .
BIOCHEMISTRY, 1988, 27 (07) :2253-2259
[10]   THE 24 KDA N-TERMINAL SUBDOMAIN OF THE DNA GYRASE-B PROTEIN BINDS COUMARIN DRUGS [J].
GILBERT, EJ ;
MAXWELL, A .
MOLECULAR MICROBIOLOGY, 1994, 12 (03) :365-373